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Abstract
Astrocytes support neuronal function by providing essential structural and nutritional support, neu-
rotransmitter trafficking and recycling and may also contribute to brain information processing. In
this article we review published results and report new data suggesting that astrocytes function as
versatile metabolic sensors of central nervous system (CNS) milieu and play an important role in
the maintenance of brain metabolic homeostasis. We discuss anatomical and functional features of
astrocytes that allow them to detect and respond to changes in the brain parenchymal levels of
metabolic substrates (oxygen and glucose), and metabolic waste products (carbon dioxide). We
report data suggesting that astrocytes are also sensitive to circulating endocrine signals—hormones
like ghrelin, glucagon-like peptide-1 and leptin, that have a major impact on the CNS mechanisms
controlling food intake and energy balance. We discuss signaling mechanisms that mediate com-
munication between astrocytes and neurons and consider how these mechanisms are recruited by
astrocytes activated in response to various metabolic challenges. We review experimental data
suggesting that astrocytes modulate the activities of the respiratory and autonomic neuronal net-
works that ensure adaptive changes in breathing and sympathetic drive in order to support the
physiological and behavioral demands of the organism in ever-changing environmental conditions.
Finally, we discuss evidence suggesting that altered astroglial function may contribute to the
pathogenesis of disparate neurological, respiratory and cardiovascular disorders such as Rett syn-
drome and systemic arterial hypertension.
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1 | INTRODUCTION
Living cells generate a constant supply of adenosine triphosphate (ATP)
to provide the energy required to carry out fundamental cellular proc-
esses, such as cytoskeleton assembly, maintenance of membrane
potential and excitability, membrane transport, cell movement/migra-
tion, intracellular and intercellular signaling. A complex hierarchy of
behavioral, physiological and biochemical mechanisms ensure adequate
delivery of metabolic substrates and effective elimination of metabolic
waste products from all tissues of the body (Fell, 1997).
The central nervous system (CNS) plays a key role in the mainte-
nance of energy homeostasis. This function requires specific sensors
that can rapidly respond to perturbations in themetabolic milieu. A series
of seminal studies identified groups of neuronal metabolic sensors
located in discrete brain areas, particularly in the hypothalamus and the
brainstem (Anand, Chhina, Sharma, Dua, & Singh, 1964; Oomura et al.,
1964; Oomura, Nakamura, Sugimori, & Yamada, 1975; Loeschcke,
1982). Like all brain cells, these neurons use metabolic substrates to sat-
isfy their own metabolic needs, but in addition, they also have the ability
to respond to variations in the availability of specific substrates with
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changes in membrane excitability, neurotransmitter release and gene
expression. This, in turn, results in adaptive physiological responses that
control multiple aspects of energy balance such as oxygen delivery, car-
bon dioxide elimination and feeding behavior, among others. More
recently it has become evident that CNSmetabolic sensing is more com-
plex than originally thought andmay involve glial cells in an active role.
In this special issue of GLIA we discuss the emerging evidence sup-
porting the hypothesis that astrocytes function as versatile metabolic
sensors of CNS milieu and by doing so play an important role in the
maintenance of brain metabolic homeostasis. Cellular features of astro-
cytes allow them to detect and respond to changes in the brain paren-
chymal levels of metabolic substrates and metabolic waste products.
Astrocytes are also sensitive to circulating hormones that modulate the
activities of the neuronal circuits controlling food intake and energy
balance. Recent evidence suggests that astrocytes modulate the activ-
ities of vital respiratory and autonomic neuronal networks that control
breathing and autonomic balance while compromised astroglial func-
tion may contribute to the development and progression of disparate
neurological, respiratory and cardiovascular diseases.
2 | ASTROCYTES
Astrocytes support neuronal function by providing structural and nutri-
tional support as well as by facilitating neurotransmitter trafficking and
recycling. There is also significant evidence to suggest that astrocytes
contribute to CNS information processing (Halassa et al., 2009;
Papouin, Dunphy, Tolman, Foley, & Haydon, 2017). The morphological
and functional adaptations of astrocytes ideally position them to act as
physiological sensors of brain metabolic milieu: (i) Sensory input: per-
turbations in metabolic milieu as well as systemic hormonal signals are
detected by astrocytes residing in the hypothalamus and the brainstem
(Chowen et al., 1999; Cheunsuang & Morris, 2005; Angelova et al.,
2015; Garcia-Caceres et al., 2016; Turovsky et al., 2016). Astroglial
processes and end feet surrounding the cerebral vasculature form one
of the key elements of the blood–brain barrier. As a result, astrocytes
are ideally placed to sense blood-borne metabolic and endocrine signals
(Kacem, Lacombe, Seylaz, & Bonvento, 1998; Sofroniew & Vinters,
2010); (ii) Transduction mechanisms: astrocytes are not electrically
excitable but display so-called “Ca21 excitability” responding to various
stimuli (e.g., chemical, mechanical, etc.) and certain neuronal cues with
increases in intracellular [Ca21] (Zheng et al., 2015; Bazargani & Att-
well, 2016) followed by intracellular changes and/or the release of vari-
ous signaling molecules (“gliotransmitters”). (iii) Neuromodulatory
output: astrocytes have a dense network of finely branching processes
that enwrap neuronal synapses forming one of the components of the
so-called “tripartite synapse” (Perea, Navarrete, & Araque, 2009). These
processes contain membrane proteins that play important roles in
ensuring effective synaptic transmission such as glutamate transporters
(Chaudhry et al., 1995), potassium channels (Higashi et al., 2001; Olsen,
2012), aquaporins (Thrane et al., 2011), and lactate transporters
(Puchades, Sogn, Maehlen, Bergersen, & Gundersen, 2013). Increases
in intracellular [Ca21] in astrocytes can also trigger the release of glio-
transmitters that interact with pre- and post-synaptic receptors and
can potentially control neuronal network activity via modulation of syn-
aptic transmission and neuronal excitability (Perea et al., 2009). Several
molecules have been suggested to function as gliotransmitters, includ-
ing ATP/adenosine, polyphosphate, D-serine, glutamate, GABA, and lac-
tate (Volterra & Meldolesi, 2005; Rollenhagen et al., 2007; Holmstrom
et al., 2013; Tang et al., 2014; Marina et al., 2015; Martin, Bajo-
Graneras, Moratalla, Perea, & Araque, 2015; Papouin et al., 2017).
Thus, astrocytes appear to be strategically positioned tomonitor the
chemical composition of the arterial blood entering the brain, integrate it
with the metabolic signals arising from the brain parenchyma and com-
municate this information to intermingled neuronal networks, enabling
the initiation of coordinated adaptive physiological and behavioral
responses that ensure homeostasis in dynamic environmental conditions
(Gourine, 2005; Gourine & Kasparov, 2011; Teschemacher, Gourine, &
Kasparov, 2015). Astrocytes are also at the center of the neurovascular
interface and are able to release vasoactive molecules that regulate cere-
bral blood flow in accord with prevailing neuronal activity. This facilitates
the supply of oxygen and glucose and the removal of CO2 in a process
known as neurovascular coupling (Attwell et al., 2010).
3 | ASTROCYTES AS CNS METABOLIC
SENSORS
3.1 | Sensing oxygen
Aerobic respiration is the key cellular process which breaks down meta-
bolic substrates to produce molecules of ATP. In air-breathing animals
the supply of oxygen and the removal of carbon dioxide involve the
transfer of air between the atmosphere and the lungs by the process of
alveolar ventilation, the diffusion of gas between alveoli and the pulmo-
nary blood and the transport of oxygen and carbon dioxide to and from
all tissues of the body, respectively. The partial pressure of oxygen
(PO2) in the arterial blood is sensed by the peripheral oxygen chemo-
receptors located in the carotid bifurcation and in the aortic arch (in
some species). The chemosensitive glomus cells of the carotid body are
traditionally considered to be the primary (and only) respiratory oxygen
sensors in mammals. When activated by hypoxia, carotid bodies initiate
a chemoreflex that results in activation of the respiratory and sympa-
thetic circuits located in the brainstem. This leads to rapid respiratory
and cardiovascular responses directed towards restoring the arterial
PO2 (Guyenet, 2006; Kumar & Prabhakar, 2012). However, there is sig-
nificant evidence that all mammals can survive denervation of the
peripheral oxygen sensors and that hypoxic ventilatory response recov-
ers in experimental animals whose carotid bodies have been surgically
denervated or removed, suggesting that the brain may also contain
functional respiratory oxygen sensors (Davenport, Brewer, Chambers,
& Goldschmidt, 1947; Miller & Tenney, 1975; Olson, Vidruk, & Demp-
sey, 1988; also see Gourine & Funk, 2017 for a comprehensive review).
Results of recent studies suggested that astrocytes may function
as physiological sensors of brain oxygenation (Figure 1; Angelova et al.,
2015). This was demonstrated using two-photon imaging of cortical
astrocytes in anesthetized and mechanically ventilated rats, where
decreases in inspired O2 (from 21% to 15% or 10%) were found to trig-
ger robust increases in astroglial [Ca21]i (Angelova et al., 2015;
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Figure 2). In vitro experiments revealed that oxygen sensitivity is a gen-
eral feature of brain astrocytes and that the hypoxia sensor is located
in the mitochondria. Simultaneous measurements of mitochondrial
membrane potential (Dwm) and [Ca
21]i in cultured astrocytes showed
that a decrease in PO2 causes a significant decrease in Dwm and that
this response precedes increases in [Ca21]i (Figure 2d). Inhibition of
mitochondrial respiration in these conditions was accompanied by
increases in mitochondrial reactive oxygen species (ROS) production.
Both hypoxia-induced ROS production and [Ca21]i responses in astro-
cytes were markedly reduced or abolished by mitochondrial uncoupler
(FCCP), mitochondrial antioxidant (MitoQ) or ROS scavenger
(a-tocopherol). Subsequent pharmacological analysis of Ca21 responses
suggested a feasible hypoxia-sensitive signaling pathway: in astrocytes
hypoxia leads to inhibition of mitochondrial respiration, increased pro-
duction of free radicals, lipid peroxidation, activation of phospholipase
C and recruitment of Ca21 from IP3-sensitive intracellular stores (Figure
1) (Angelova et al., 2015).
It was reported that the PO2 hypoxia threshold required to trigger
Ca21 responses in astrocytes is 17 mmHg (Angelova et al., 2015).
Normal level of arterial PO2 is 100 mmHg. Normal level of brain
parenchymal PO2 is between 20 and 30 mmHg with little difference
between the mammalian species (Erecinska & Silver, 2001). A study
conducted in climbers of Mt Everest reported mean arterial PO2 of
25 mmHg in four individuals breathing ambient air at 8400 m above
sea level (Grocott et al., 2009). Although we do not know what was the
brain tissue PO2 in these conditions, these fascinating data suggest that
the brain can operate in a very low oxygen environment (the partici-
pants were able to perform complex tasks), with parenchymal PO2 suf-
ficiently low to trigger astroglial activation and downstream
sympathetic, respiratory and regional cerebrovascular responses (see
below).
Experiments conducted to visualize vesicular fusion events in cul-
tured rat brainstem astrocytes using total internal reflection fluores-
cence microscopy demonstrated that reductions in PO2 facilitate
exocytosis of ATP-containing vesicles (Angelova et al., 2015; Figure 1).
Earlier in vitro and in vivo experiments using amperometric enzymatic
ATP biosensors (Gourine et al., 2007; Gourine et al., 2008) showed
that brain tissue hypoxia is indeed associated with the release of ATP,
specifically in the brainstem areas which harbor the respiratory and
sympathetic neuronal circuits (Gourine, Llaudet, Dale, & Spyer, 2005).
Activation of these networks by ATP triggers compensatory cardiores-
piratory responses that facilitate central respiratory drive, alveolar ven-
tilation and oxygen transport.
The rhythm and pattern of breathing are generated by complex
neuronal interactions within the so-called brainstem ventral respiratory
column that extends from the dorsolateral pons to the caudal regions
of the medulla oblongata (Feldman, Mitchell, & Nattie, 2003; Feldman,
Del Negro, & Gray, 2013). The brainstem respiratory network ensures
that the frequency, depth and pattern of lung ventilation are always
adequate to maintain blood and brain PO2, PCO2 and pH within physi-
ological ranges. Neurons that constitute the brainstem respiratory-
rhythm generating circuits express ATP receptors and are strongly
excited by ATP (Thomas & Spyer, 2000; Gourine, Atkinson, Deuchars,
& Spyer, 2003; Huxtable et al., 2009). Recent data demonstrated that
ATP, released by brainstem astrocytes in response to hypoxia, contrib-
utes to the development of the hypoxic ventilatory response (Angelova
et al., 2015; Rajani et al., 2017). In rats, blockade of astroglial signaling
FIGURE 1 Hypothesized cellular mechanisms underlying astroglial
oxygen and CO2/pH sensitivities. (a) The astroglial signaling
cascade triggered by hypoxia involves inhibition of mitochondrial
respiration, facilitated formation of reactive oxygen species (ROS),
lipid peroxidation, activation of phospholipase C (PLC), IP3
receptors, release of Ca21 from the intracellular stores and
enhanced vesicular release of ATP. Hypoxia may also alter opening
probability of connexin (Cx) hemichannels permeable to ATP and
lactate. (b) Increases in PCO2 gate open Cx hemichannels in Ca
21
and pH-independent manner allowing rapid egress of ATP in
response to hypercapnia. If hypercapnic stimulus is persistent,
intracellular acidification will occur and will eventually close Cx
hemichannels. In conditions of decreased pHi, astrocytes continue
to release ATP by Ca21-dependent exocytotic release mechanism.
Intracellular acidification activates Na1/HCO23 cotransport (NBC)
which brings Na1 inside the cell. Raising [Na1]i activates Na
1/Ca21
exchanger (NCX) to operate in a reverse mode leading to Ca21
entry. Released ATP acting in autocrine and paracrine manner
spreads astroglial Ca21 signals within the neuropil and enhances
respiratory and sympathetic activities via excitation of the respira-
tory rhythm generating circuits of the pre-B€otzinger complex
(preB€otC), retrotrapezoid nucleus (RTN) neurons and sympathoex-
citatory (pre-sympathetic) neurons of the brainstem
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in the ventral regions of the brainstem by overexpression of ATP-
degrading enzymes or targeted astrocyte-specific expression of tetanus
toxin light chain (to block vesicular release mechanisms) was found to
be associated with a significant reduction of the hypoxic ventilatory
response. These data strongly suggested that the central stimulatory
effect of hypoxia on breathing is mediated by an astroglial purinergic
signaling mechanism (Angelova et al., 2015; Rajani et al., 2017).
The hypoxic ventilatory response is also accompanied by a coordi-
nated cardiovascular response to ensure effective delivery of the oxy-
genated blood to all tissues of the body. Oxygen delivery is determined
by cardiac output that is controlled (among other factors) by the
activities of the sympathetic and parasympathetic branches of the
autonomic nervous system. Groups of sympathoexcitatory (pre-sympa-
thetic) brainstem neurons, including bilateral populations of catechola-
minergic C1 neurons, are essential for the generation of cardiovascular
sympathetic tone (Ross et al., 1984; Reis, Golanov, Ruggiero, & Sun,
1994; Guyenet, 2006; Marina et al., 2011; Wenker et al., 2017). These
neurons send monosynaptic projections to sympathetic preganglionic
neurons in the intermediolateral spinal cord, which in turn project to
sympathetic ganglia innervating peripheral targets, including the heart,
kidneys and the resistance arterioles of the skeletal muscle (Guyenet,
2006; Guyenet et al., 2013). There is strong evidence that the activities
of the brainstem pre-sympathetic neuronal circuits are modulated by
astrocytes (Marina et al., 2013; Marina et al., 2015). It was reported
that [Ca21]i responses in astrocytes induced by optogenetic stimulation
lead to excitation of neighboring C1 neurons in the brainstem slices in
vitro and trigger increases in renal sympathetic nerve activity, heart
rate and the systemic arterial blood pressure in anesthetized rats in vivo
(Marina et al., 2013).
The physiological significance of astroglial control of pre-
sympathetic brainstem neurons becomes apparent during central
hypoxia. These sympathoexcitatory neurons are known to be highly
sensitive to decreases in local tissue PO2 or cytotoxic hypoxia,
responding with profound excitation leading to generalized increases in
central sympathetic drive (Sun & Reis, 1994; D’Agostino, Mazza, &
Neubauer, 2009; Marina et al., 2015). It appears that the sensitivity of
C1 pre-sympathetic neurons to hypoxia is largely indirect, and medi-
ated by the actions of ATP and lactate released by neighboring astro-
cytes (Figure 1). First, hypoxia-induced excitation of C1 neurons was
found to be markedly reduced by blockade of either metabotropic ATP
receptors or inhibition of glycogenolysis (Marina et al., 2015). Second,
excitation of C1 neurons following optogenetic stimulation of astro-
cytes was significantly reduced in the presence of an ATP-degrading
enzyme apyrase (Marina et al., 2013). Third, exogenous ATP and
FIGURE 2 Astrocytes are sensitive to physiological decreases in PO2. (a) In vivo imaging of hypoxia-evoked astrocytic [Ca
21]i responses in
somatosensory cortex of an anesthetized adult rat. Top: pseudocolored images showing changes in oregon green BAPTA 1 (OGB1) fluores-
cence taken at times indicated by arrows on the bottom panel. 5–7—non-responding cells that were not labeled with sulforhodamine 101
(SR101). Bottom: traces showing changes in astrocytic [Ca21]i in response to hypoxia. Inset: averaged changes in OGB1 fluorescence
induced by hypoxia in ten SR101 labeled cells (SR1011, putative astrocytes) and five neighboring cortical cells that lacked SR101 labeling
(SR1012, likely neurons) recorded in this experiment; (b) hypoxia-induced [Ca21]i responses of carotid body glomus cells in culture, visual-
ized using Ca21 indicator Fura-2 (PO2 threshold of activation 40 mmHg). Inset: pseudocolored images of a cluster of glomus cells showing
changes in Fura-2 fluorescence in response to hypoxia (hypoxic conditions in vitro were induced by gradual displacement of oxygen in the
incubation medium with argon); (c) hypoxia-induced [Ca21]i responses of brainstem astrocytes (PO2 threshold of activation 15 mmHg). In
this example astrocytes were identified and their responses to hypoxia were assessed in organotypic brainstem slice in vitro using geneti-
cally encoded Ca21 sensor Case12 expressed under the control of GFAP promoter; (d) simultaneous imaging of hypoxia-induced changes in
Dwm and [Ca21]i in cultured brainstem astrocytes using Rhodamine 123 and Fura-2 showing that mitochondrial depolarization precedes
Ca21 responses. Mitochondrial depolarization is induced by FCCP (1 mM) applied at the end of the experiment to calibrate the Rh123 signal
(100%). Reproduced from Angelova et al. (2015) with permission from the Society for Neuroscience
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L-lactate induced potent excitation of C1 neurons in vitro and triggered
sympathoexcitatory effects similar to those observed following optoge-
netic activation of brainstem astrocytes or brain hypoxia in vivo (Sun,
Wahlestedt, & Reis, 1992; Horiuchi, Potts, Tagawa, & Dampney, 1999;
Ralevic, 2000; Marina et al., 2015). Finally, hypoxia facilitated release
of both ATP (Gourine et al., 2005) and lactate (Karagiannis et al., 2016;
Hadjihambi et al., 2017) in brainstem regions containing populations of
pre-sympathetic neurons. While the effect of ATP on C1 neuronal
activity is mediated by P2X and P2Y receptors (Sun et al., 1992;
Ralevic, 2000; Wenker, Sobrinho, Takakura, Mulkey, & Moreira, 2013),
the mechanisms underlying the excitatory effects of lactate remain
unknown but appear to involve activation of as yet uncharacterized
lactate-sensitive Gs coupled receptor (Tang et al., 2014).
The experimental data reviewed and discussed above suggest that
astrocytes are intrinsically sensitive to hypoxia and play an important
role in the development of coordinated ventilatory and cardiovascular
responses to decreases in brain (stem) PO2. There is also evidence that
astroglial oxygen sensitivity may contribute to the pathogenesis of cer-
tain diseases associated with brain hypoxia. Congestive heart failure
and systemic arterial hypertension are highly prevalent conditions char-
acterized by sustained increases in sympathetic nerve activity, which is
generally believed to have long-term detrimental effects and contribute
to the disease progression (Naughton et al., 1995; Esler et al., 2001;
Mansfield et al., 2003). Human and experimental animal studies
revealed that both heart failure and systemic arterial hypertension are
associated with lower brain PO2 even when arterial PO2 is within the
normal physiological range (Rifai, Winters, Friedman, & Silver, 2012;
Marina et al., 2015; Turlejski, Humoud, Desai, Smith, & Marina, 2016;
Hosford, Millar, Ramage, & Marina, 2017). The mechanisms underlying
compromised brain oxygenation in these conditions are complex and
remain poorly understood (Cates, Steed, Abdala, Langton, & Paton,
2011; Cates, Dickinson, Hart, & Paton, 2012; Marina et al., 2015;
Marina, Teschemacher, Kasparov, & Gourine, 2016), however, brain-
stem parenchymal hypoxia might contribute to sustained excitation of
the pre-sympathetic circuits via the actions of ATP and lactate released
by astrocytes at low tissue PO2 (Marina et al., 2013; Marina et al.,
2015). To test this hypothesis, two studies in rats used viral gene tar-
geting of pre-sympathetic regions of the brainstem to overexpress a
potent ectonucleotidase—transmembrane prostatic acid phosphatase.
Activity of this enzyme effectively prevents vesicular accumulation of
ATP (Wells et al., 2015) and facilitates degradation of extracellular ATP
(Marina et al., 2013). Blockade of ATP-mediated signaling within the
pre-sympathetic brainstem regions slowed the progression of cardiac
remodeling in animals with myocardial infarction-induced heart failure
(Marina et al., 2013) and reduced systemic arterial blood pressure in
spontaneously hypertensive rats (Marina et al., 2015). Subsequent
studies provided further evidence of brainstem tissue hypoxia and
astrogliosis in hypertensive rats (Turlejski et al., 2016). Together these
data support the hypothesis that sustained astroglial activation in con-
ditions of brainstem tissue hypoxia might be responsible for maintain-
ing heightened sympathetic drive that contributes to the development
and progression of cardiovascular disease (Marina et al., 2013; Marina
et al., 2015; Marina et al., 2016).
Finally, there is evidence that brain tissue PO2 is the key metabolic
factor that determines the direction of cerebral arteriole response (con-
striction at high PO2 and dilatation at physiological/low PO2) that fol-
low astroglial [Ca21]i elevations (Gordon, Choi, Rungta, Ellis-Davies, &
MacVicar, 2008). Since Ca21-dependent release of vasoactive substan-
ces by astrocytes can alter cerebral blood flow (Attwell et al., 2010;
Mishra et al., 2016; Bazargani & Attwell, 2016), the mechanism of
direct oxygen sensing by astrocytes (Angelova et al., 2015) may be
important for the regulation of cerebral microcirculation in conditions
of increased local oxygen demand or regional brain tissue hypoxia.
While this hypothesis awaits experimental scrutiny, the available data
strongly suggest that detection of hypoxia by brainstem astrocytes
stimulates the networks of the respiratory and pre-sympathetic neu-
rons and contributes to the development of the ventilatory and cardio-
vascular responses which ensure appropriate oxygenation and delivery
of the arterial blood.
3.2 | Sensing glucose
Glucose is an important source of energy and a substrate for many bio-
chemical reactions. Blood glucose level fluctuates between 70 and
100 mg dl21 throughout a 24-hr period in fasting conditions and may
increase up to 140 mg dl21 within the first 2 hr after ingestion of a
meal. Intricate neural and hormonal control mechanisms operate to
maintain blood glucose level within a physiological range and to ensure
that the metabolic demands of all tissues of the body, and of the brain
in particular, are satisfied.
Diabetic patients treated with insulin and sulphonylureas are at
increased risk of acute hypoglycemia. Hypoglycemia can have profound
deleterious effects on the neuronal function, leading to permanent
brain damage and even death (Frier, 2014). Sustained elevations in
plasma glucose can also have various adverse effects on vital organs,
including the brain. Therefore, physiological glucose sensing is critically
important for homeostasis which is ensured via recruitment of the hor-
monal (insulin and glucagon secretion), autonomic (liver glucose pro-
duction) and behavioral (feeding initiation and termination)
mechanisms.
There is evidence that brainstem astrocytes may function as CNS
glucose sensors. Mice with genetic deletion of the glucose transporter
type 2 (GLUT2) were not able to respond to systemic hypoglycemia
with increased glucagon secretion (Marty et al., 2005). However, the
capacity to release glucagon in response to hypoglycemia was restored
by selective re-expression of GLUT2 in the brainstem glial cells, but not
in neurons (Marty et al., 2005). An earlier study reported that
hypoglycemia-induced activation of neurons in the hypothalamus and
the brainstem was blocked in conditions when astroglial glutamate
metabolism was compromised by application of glutamine synthetase
inhibitor methionine sulfoximine (Young, Baker, & Montes, 2000).
Together, these data suggest that detection of hypoglycemia by the
brain may require metabolic coupling and signaling between astrocytes
and neurons. Consistent with this hypothesis, astrocytes have been
shown to control (via release of lactate) the activities of hypothalamic
orexin neurons which promote arousal, stimulate food intake and
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hepatic glucose production (Parsons & Hirasawa, 2010). However, the
cellular and molecular mechanisms underlying glucose sensitivity of
astrocytes remain to be determined.
Recently, Garcia-Caceres and colleagues (2016) reported data sug-
gesting that astroglial insulin signaling modulates hypothalamic glucose
sensing and systemic glucose metabolism. The authors demonstrated
that ablation of insulin receptors in hypothalamic astrocytes reduced
glucose-induced activation of pro-opio-melanocortin neurons and
impaired physiological responses to changes in glucose availability. Fol-
lowing systemic glucose administration, cerebrospinal fluid accumula-
tion of glucose and insulin were found to be reduced in mice lacking
astroglial insulin receptors. The authors concluded that brain glucose
sensing and, therefore, systemic glucose metabolism are controlled, at
least in part, by insulin acting at hypothalamic astrocytes. Moreover,
the data reported by Garcia-Caceres et al. (2016) also suggested that
astroglial insulin receptors play an important role in modulating glucose
transfer across the blood–brain barrier.
3.3 | Sensing carbon dioxide and pH
Metabolic homeostasis also requires effective elimination of waste
products. Carbon dioxide is generated in proportion to the metabolic
rate and the amount of metabolic substrates utilized. At rest, our body
produces 12 mmol kg21 h21 of CO2; most of which is removed with
expired air through the process of alveolar ventilation. The partial pres-
sure of CO2 (PCO2) in the arterial blood is directly proportional to the
rate of CO2 production and inversely proportional to the rate of CO2
elimination by the respiratory system. Increased CO2 production and/
or impaired CO2 elimination facilitate generation of hydrogen ions
(respiratory acidosis), a condition that needs to be rapidly corrected by
adaptive changes in the ventilatory and cardiovascular activities in
order to ensure effective CO2 removal.
It is generally believed that changes in the arterial and brain PCO2/
pH are monitored by specialized pH-sensitive neurons residing in the
brainstem (Loeschcke, 1982). Current models of central respiratory
CO2 chemosensitivity (the mechanism that adjusts breathing in accord-
ance with changes in brainstem parenchymal PCO2/pH) are focused on
a group of pH-sensitive neurons of the retrotrapezoid nucleus (RTN)
located near the ventral surface of the brainstem (Guyenet, & Mulkey,
2010). This view is supported by the results of the experimental studies
which demonstrated that the permanent loss or acute silencing of RTN
neurons abolishes or significantly reduces ventilatory CO2 sensitivity
(Dubreuil et al., 2008; Guyenet et al., 2009; Guyenet & Mulkey, 2010;
Marina et al., 2010; Ramanantsoa et al., 2011). Although other notable
groups of brainstem neurons, including 5-HT neurons of the raphe
nuclei, are intrinsically chemosensitive (Teran, Massey, & Richerson,
2014) and contribute to the development of the ventilatory response
to CO2 (Ray et al., 2011), the current prevailing view is that pH-
sensitive RTN neurons play the key role (Guyenet et al., 2016).
However, there is evidence that pH-sensitivity of RTN neurons is,
to a large extent, indirect and mediated by the responses triggered by
the chemosensory stimuli in the neighboring astrocytes (Gourine et al.,
2010). Experiments conducted in anesthetized and mechanically
ventilated rats demonstrated that astrocytes residing near the ventral
surface of the brainstem (within the RTN region) respond to decreases
in pH with robust elevations in intracellular [Ca21] (Gourine et al.,
2010; Figure 3). This triggers Ca21-dependent vesicular release of ATP
(Gourine et al., 2010; Kasymov et al., 2013) which propagates Ca21
excitation among neighbouring astrocytes, activates RTN neurons
(Gourine et al., 2010) as well as respiratory neurons that constitute
other functional divisions of the ventral respiratory column (Gourine
et al., 2003).
The mechanisms linking the detection of PCO2/[H
1] increases
with [Ca21]i responses in brainstem astrocytes are dependent on the
activities of certain membrane transporters (Turovsky et al., 2016).
Astroglial [Ca21]i responses triggered by CO2-induced acidification
(respiratory acidosis) were found to be preceded by Na1 entry, reduced
by inhibition of the Na1/HCO23 cotransport (NBC) or Na
1/Ca21
exchange (NCX) and abolished in the absence of extracellular Na1.
Acidification-induced Ca21 responses were also dramatically reduced
in brainstem astrocytes of mice deficient in the electrogenic Na1/
HCO23 cotransporter NBCe1 (Turovsky et al., 2016). Thus, coupled
NBC and NCX activities appear to underlie functional pH-sensitivity of
brainstem astrocytes leading to the increases in intracellular [Ca21]
(Figure 1).
Ventral brainstem astrocytes also possess the mechanism of direct
CO2 sensing (Huckstepp et al., 2010) which operates via modulation of
connexin-26 hemichannel opening (Meigh et al., 2013). The CO2-
dependent hemichannel-mediated release of ATP operates independ-
ently of astroglial pH sensing mechanism(s), since pharmacological
agents which block functional connexin hemichannels have little effect
on acidification-induced Ca21 responses in brainstem astrocytes
(Gourine et al., 2010).
Unlike direct oxygen sensing which is a ubiquitous feature shared
between astrocytes residing in different CNS regions (Angelova et al.,
2015), CO2/pH sensitivity appears to be a unique feature of specialized
astrocytes which populate the brainstem areas at and in a close prox-
imity to its ventral surface (Gourine et al., 2010; Kasymov et al., 2013;
Turovsky et al., 2016). This was demonstrated in a comparative study
where only brainstem astrocytes were found to display responses to
pH challenges (Kasymov et al., 2013). Transcriptome analysis identified
NBCe1 expression to be markedly higher in the brainstem astrocytes
compared with that in cortical astrocytes (Turovsky et al., 2016). Brain-
stem astrocytes also showed significantly higher expression of another
notable astroglial gene, KCNJ10 (Turovsky et al., 2016), which encodes
the KIR4.1 subunit of inwardly rectifying K
1 channel. In mice,
astrocyte-specific conditional deletion of KIR4.1 was reported to impair
ventilatory CO2 chemosensitivity (Hawkins et al., 2014).
CO2-induced hemichannel-mediated and/or acidification-induced
vesicular release of ATP by brainstem astrocytes contributes to the
homeostatic regulation of brain pH by triggering adaptive changes in
the brainstem respiratory network activity and, therefore, lung ventila-
tion, facilitating CO2 removal. Systemic hypercapnia (induced by
increases in inspired CO2) in anesthetized and mechanically ventilated
rats was reported to trigger release of ATP from the ventral brainstem
surface (Gourine et al., 2005; Huckstepp, Llaudet, & Gourine, 2016).
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This CO2-induced release of ATP was dependent upon the structural
integrity of the subpial astrocyte layer and occurred prior to the
increases in central respiratory drive (Gourine et al., 2005; Huckstepp
et al., 2010). Furthermore, CO2-induced ventilatory responses were sig-
nificantly reduced following blockade of ATP receptors at the sites of
release (Gourine et al., 2005). The effect of CO2 on breathing was mim-
icked by application of ATP to the brainstem sites of release as well as
by optogenetic stimulation of brainstem astrocytes (Gourine et al.,
2005; Gourine et al., 2010; Figueiredo et al., 2011).
Impaired astroglial mechanisms may contribute to the develop-
ment of abnormal breathing patterns observed in some prototypical
neurological disorders. In humans, mutations of the transcriptional reg-
ulator methyl-CpG-binding protein 2 (MeCP2) gene lead to a neurode-
velopmental disorder called Rett syndrome, which is characterized by
irregular breathing pattern and blood gas instability (Southall et al.,
1988; Viemari et al., 2005; Ramirez, Ward, & Neul, 2013). MeCP2 is
highly expressed in astrocytes (Yasui et al., 2013) and loss of MeCP2
leads to astroglial dysfunction (Okabe et al., 2012). In a mouse model
of Rett syndrome (global MeCP2 gene knockout), sensitivity of brain-
stem astrocytes to changes in PCO2/pH is markedly reduced (Turovsky,
Karagiannis, Abdala, & Gourine, 2015) and ventilatory CO2 sensitivity is
severely impaired (Bissonnette, Schaevitz, Knopp, & Zhou, 2014).
Moreover, it was reported that in mice, conditional astrocyte-specific
deletion of MeCP2 is sufficient to dramatically impair CO2-induced ven-
tilatory response (Garg, Lioy, Knopp, & Bissonnette, 2015). Remarkably,
in global MeCP2 gene knockout mice, selective re-expression of
MeCP2 in astrocytes rescues the normal respiratory pattern (Lioy et al.,
2011). These data indicate that the brainstem networks of the respira-
tory neurons, including chemosensitive RTN neurons, are not able to
mount an appropriate ventilatory response to CO2 when astroglial
function and pH-sensitivity are compromised, supporting the idea of a
critical role played by astroglial pH-sensitivity in the CNS mechanisms
FIGURE 3 Astrocytes residing near the ventral surface of the brainstem are exquisitely pH-sensitive. (a) In vivo imaging of pH-evoked
astrocytic [Ca21]i responses in the ventrolateral area of the brainstem surface transduced with AVV-sGFAP-Case12 in an anesthetized adult
rat. Exposed ventral brainstem surface was continuously superfused with HEPES-buffered solutions of variable pH and bulk [Ca21]i
responses to a 0.2 unit pH decrease were recorded. A large area of the brainstem was imaged at low magnification, therefore, regions of
interest in this case encompass multiple astrocytes which cannot be individually resolved under these imaging conditions. Right traces:
changes in astrocytic [Ca21]i in response to a decrease in pH. Pseudocolored images (left) were taken at times indicated by blue arrows.
Squares indicate regions of interest. The pH bar shows when the solution with lower pH is reaching and starts leaving the exposed ventral
surface of the brainstem. Dashed line outlines approximate boundary of the chemosensitive retrotrapezoid nucleus. py—pyramidal tract. (b)
Astrocytes identified by Case12 fluorescence in a horizontal slice from an adult rat in which the ventral brainstem was transduced with
AVV-sGFAP-Case12. Acidification induces rapid increases in [Ca21]i as determined by changes in Case12 fluorescence. Two fluorescent
images obtained before and at the peak of [Ca21]i response. Circle indicates an astrocyte responding first to pH change in the field of view.
Yellow arrow shows the direction of the flow in the chamber. (c) Zoomed in Ca21 transients to emphasize the latency differences between
responses of individual astrocytes shown in (b). (d) No effect of TTX or muscimol on acidification-induced [Ca21]i responses in brainstem
astrocytes expressed as percentage of the peak initial response. Numbers of individual astrocytes sampled from 3–5 separate experiments
are given in brackets. (e) Acidification-evoked [Ca21]i responses in astrocytes of organotypic brainstem slice transduced with AVV-sGFAP-
Case12. (f) Brainstem vasculature visualized with lectin in a horizontal slice prepared from an AVV-sGFAP-Case12–transduced rat. Arrows
point at pH-responsive astrocytes. Reproduced from Gourine et al. (2010) with permission from AAAS
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which transmit changes in brain parenchymal PCO2/pH into a modified
pattern of breathing. It remains to be determined whether astroglial
dysfunction may also contribute to the expression of altered breathing
patterns (e.g., central sleep apnoea) observed in some other pathologi-
cal conditions.
Finally, a recent study has suggested that astrocytes may also
mediate cerebrovascular responses to CO2. Howarth and colleagues
(2017) reported that in anesthetized mice, increases in the level of
inspired CO2 trigger [Ca
21]i responses in cortical astrocytes, which in
turn may evoke cerebral vessel dilations via stimulation of COX-1 activ-
ity followed by PgE2 release and its action on cerebrovascular smooth
muscle cells (Howarth et al., 2017).
4 | ASTROCYTES AS CNS SENSORS OF
METABOLIC ENDOCRINE SIGNALS
Metabolic homeostasis is ensured by coordinated adaptive physiologi-
cal and behavioral responses to a multitude of endogenous and envi-
ronmental factors and most importantly by the availability of nutrients.
The control of food intake in particular is generally believed to depend
on the ability of specialized neurons located in the hypothalamus and
the brainstem to detect and integrate various humoral and afferent
neuronal signals which provide information about the nutritional state
and energy demands of the organism (Caron & Richard, 2017). Consid-
ering that astrocytes function as CNS metabolic sensors we next
explored whether these glial cells are sensitive to endocrine metabolic
signals released from the gut and the adipose tissue. The data reported
below were obtained using standard experimental models and proto-
cols described in detail in our previous publications (Gourine et al.,
2010; Kasymov et al., 2013; Angelova et al., 2015; Turovsky et al.,
2015; Turovsky et al., 2016).
4.1 | Ghrelin
Ghrelin (also known as growth hormone-releasing peptide) is the only
circulating peptide known to stimulate appetite and increase food
intake. Ghrelin is mainly produced and released by oxyntic glands of
the gastric fundus and its CNS actions increase food intake, produce
weight gain, and promote adiposity via increased production of
orexigenic neuropeptides such as neuropeptide Y and Agouti-related
peptide (AGRP) by the neurons of the arcuate nucleus of the hypothal-
amus (Wren et al., 2001; Greenman et al., 2004). There is evidence
that the effect of ghrelin on food intake is suppressed by activation of
astrocytes which inhibit hypothalamic AGRP-producing neurons via the
release of ATP/adenosine acting at A1 receptors (Yang, Qi, & Yang,
2015).
To determine the effect of ghrelin on astrocytes we used dissoci-
ated neuroglial cultures transduced to express a genetically encoded
Ca21 indicator GCaMP6f. Astrocytes were transduced using an adeno-
associated viral vector designed to drive the expression of GCaMP6f
under the transcriptional control of the GFAP promoter (Jiang, Haus-
tein, Sofroniew, & Khakh, 2014). The majority of astrocytes expressing
GCaMP6f responded to application of a prototypical glial signaling
molecule ATP (10 mM) with elevations in [Ca21]i (Figure 4a–e). Ghrelin
triggered robust [Ca21]i responses in 30% of brainstem astrocytes
that were activated by ATP (Figure 4a). Strong [Ca21]i responses in
astrocytes were induced following application of ghrelin in concentra-
tions as little as 1 nM (Figure 4a). Ghrelin-induced [Ca21]i responses in
astrocytes were effectively blocked by ghrelin receptor (GHSR1a)
antagonist [(D-Lys3)-GMPR-6] (Figure 4d).
These data suggest that astrocytes (at least in culture) express
functional ghrelin receptors and respond to physiological concentra-
tions of ghrelin with elevations in intracellular [Ca21]. It remains to be
determined whether astrocytes in situ are sensitive to ghrelin and may
ultimately mediate or modulate the effects of ghrelin on neighboring
neurons.
4.2 | Glucagon-like peptide (GLP-1)
GLP-1 is one of many hormones known to induce satiety. GLP-1
belongs to the family of incretin peptides that are produced by the
intestinal epithelial L-cells (Tian & Jin, 2016). Actions of GLP-1 include
stimulation of glucose-dependent insulin secretion, inhibition of gluca-
gon secretion and stimulation of somatostatin secretion (Tian & Jin,
2016). GLP-1 also delays gastric emptying, inhibits gastrointestinal
motility, and contributes to the physiological control of feeding behav-
iour (Holst, 2007). GLP-1 receptors (GLP-1R) are expressed in the brain
regions involved in the control of energy metabolism, such as medio-
basal hypothalamus and the caudal brainstem (Cork et al., 2015) and
central actions of GLP-1 reduce food intake (Tang-Christensen et al.,
1996; Turton et al., 1996). There is recent evidence suggesting that
astrocytes may mediate the effects of central GLP-1R activation on
feeding behavior. Results of the experiments conducted in rat brain-
stem slices showed that astrocytes residing in the dorsal brainstem
respond to GLP-1R activation with elevations in [Ca21]i (Reiner et al.,
2016). Moreover, poisoning of dorsal brainstem astrocytes with fluoro-
citrate attenuated the effect of GLP-1R activation on food intake when
GLP-1 analog Exendin-4 (Ex-4) was administered into the same brain-
stem site (Reiner et al., 2016). However, these data should be inter-
preted with some caution since fluorocitrate is not a selective “glial
toxin” and depending on the concentration and the experimental condi-
tions could potentially inhibit tricarboxylic acid cycle of all cells.
Experiments conducted using cultures of brainstem astrocytes
transduced to express GCaMP6f revealed that relatively high concen-
trations of GLP-1R agonist Ex-4 are needed to elicit [Ca21]i responses
(Figure 4b). The threshold dose of Ex-4 required to trigger robust
[Ca21]i elevations in cultured astrocytes was found to be 100 nM
(Figure 4b). [Ca21]i responses to GLP-1R activation were observed in
30% of astrocytes that responded to the application of ATP. Ex-4-
induced [Ca21]i responses in astrocytes were abolished in the presence
of the GLP-1R antagonist Exendin 9–39 (Figure 4e). Interestingly,
astrocytes that displayed [Ca21]i responses to ghrelin were also sensi-
tive to GLP-1R activation (Figure 4c). Blockade of GLP-1R had no
effect on [Ca21]i responses triggered by ghrelin, while blockade of
GHSR1a receptors had no effect on Ex-4-induced [Ca21]i transients
(Figure 4d,e). These data suggest that individual brainstem astrocytes
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are able to respond to various endocrine signals with apparently oppos-
ing central physiological actions.
There is evidence that the central effects of GLP-1 analogs are
associated with excitation of pre-sympathetic C1 neurons, increases in
central sympathetic drive, systemic arterial blood pressure and heart
rate (Yamamoto et al., 2002). Although, these effects are likely to be
attributed to direct activation of neuronal GLP-1Rs, the data reported
and discussed above suggest that brainstem astrocytes may contribute
to GLP-1-induced sympathoexcitation via Ca21-dependent release of
signaling molecules that activate pre-sympathetic circuits (e.g., ATP).
This hypothesis can be tested in the future by recording the sympa-
thetic and cardiovascular effects of GLP-1R activation within the sym-
pathoexcitatory brainstem regions in conditions when astroglial
signaling pathways are blocked using molecular approaches.
4.3 | Leptin
Leptin is a hormone produced mainly by the white and brown adipose
tissue that plays an important role in the control of energy metabolism.
Leptin crosses the blood–brain barrier through a saturable transport
system (Banks, Kastin, Huang, Jaspan, & Maness, 1996) and induces
receptor (ObR)-mediated inhibition of the release of orexigenic pep-
tides (neuropeptide Y and AGRP) produced by the neurons of the
hypothalamic arcuate nucleus (Elias et al., 1999; van den Top, Lee,
Whyment, Blanks, & Spanswick, 2004). Leptin also stimulates the
release of anorectic peptides (e.g., pro-opio melanocortin; Elias et al.,
1999; Cowley et al., 2001). These actions of leptin inhibit appetite and
increase energy expenditure.
Previously the central effects of leptin were thought to be primar-
ily mediated via its direct actions on hypothalamic neurons and endo-
thelial cells but recent evidence suggests that some of these effects are
mediated by astrocytes. Astrocytes express several ObR splice variants
and leptin application has been shown to trigger strong and sustained
[Ca21]i responses in primary astrocytes from mouse hypothalamus
(Hsuchou, Pan, Barnes, & Kastin, 2009). Mice with genetic- and diet-
induced obesity show an upregulation of ObR expression in hypothala-
mic astrocytes and a concomitant downregulation of ObR expression
in neurons (Hsuchou et al., 2009; Pan et al., 2008). Another study
reported enhanced leptin uptake by hypothalamic neurons in the pres-
ence of fluorocitrate, suggesting that astrocytes may play a certain role
in the distribution of this hormone among different cellular compart-
ments (Pan et al., 2011).
FIGURE 4 Brainstem astrocytes are sensitive to ghrelin and GLP-1 receptor activation. (a) Representative example of astroglial [Ca21]i
responses induced by ghrelin applied in increasing concentrations. Traces depict responses of nine individual astrocytes transduced to
express Ca21 indicator GCaMP6f in culture. Here and in the other examples [Ca21]i responses triggered by ATP (10 mM) applied at the end
of the recordings confirm cell viability. (b) Representative example of astroglial [Ca21]i responses induced by GLP-1 receptor agonist
Exendin-4 applied in increasing concentrations. Traces depict responses of nine individual astrocytes in culture. (c) Representative example
of [Ca21]i responses of the same brainstem astrocytes induced by successive applications of ghrelin (10 nM) and Exendin-4 (100 nM).
Traces depict responses of eight individual astrocytes. (d) Representative recording illustrating the effect of GHSR1 antagonist [(D-Lys3)-
GMPR6] (100 mM) on [Ca21]i responses of brainstem astrocytes induced by ghrelin (100 nM) and Exendin-4 (100 nM). Individual traces of
[Ca21]i responses in 13 astrocytes are shown. (e) Representative recording illustrating the effect of GLP-1 receptor antagonist Exendin 9–
39 (1 mM) on [Ca21]i responses of brainstem astrocytes induced by Exendin-4 (100 nM) and ghrelin (100 nM). Individual traces of [Ca
21]i
changes in 11 astrocytes are shown
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Several studies conducted in rats reported that direct administration
of leptin to the pre-sympathetic regions of the brainstem triggers pro-
found and sustained increases in central sympathetic drive and systemic
arterial blood pressure (Haynes, Morgan, Walsh, Mark, & Sivitz, 1997;
Barnes & McDougal, 2014). Moreover, leptin actions in the brainstem
were found to enhance the baseline respiratory activity and ventilatory
sensitivity to CO2 in leptin deficient mice (ob/ob; Bassi et al., 2014). These
effects of leptin on the respiratory and sympathetic activities mirror the
effects of astroglial activation. However, it remained unclear whether the
cardiorespiratory effects of leptin result from its direct actions on the
respiratory and pre-sympathetic neuronal circuits or secondary to the
responses elicited by this hormone in neighboring astrocytes.
We evaluated the effect of leptin on [Ca21]i in cultured brainstem
astrocytes transduced to express the genetically encoded Ca21
FIGURE 5 Leptin-induced [Ca21]i responses in brainstem astrocytes and neurons. (a) Representative example of [Ca
21]i responses induced
by leptin (10 nM) in cultured astrocytes. Traces depict responses of 20 individual astrocytes transduced to express a Ca21 indicator Case12.
(b) Summary data illustrating peak amplitudes of astroglial [Ca21]i responses and proportion of astrocytes responding with [Ca
21]i elevations
to leptin applied in increasing concentrations. (c) Representative examples of [Ca21]i responses induced by leptin (10 nM) in astrocytes
(identified by labeling with sulforhodamine 101) in the absence and presence of an ATP receptor blocker MRS2179 (10 mM) or ATP-
hydrolyzing enzyme apyrase (50 U ml21). Traces depict responses of 8 (left) and 8 (right) individual astrocytes loaded with oregon green-
488 BAPTA-1 AM (OGB-488) in organotypic slices of the rat brainstem. (d) Representative examples of [Ca21]i responses induced by leptin
(10 nM) in neurons (identified by lack of sulforhodamine 101 labeling and robust [Ca21]i responses to KCl) in the absence and presence of
MRS2179 (10 mM) or apyrase (50 U ml21). Traces depict responses of 5 (left) and 5 (right) individual astrocytes loaded with oregon green-
488 BAPTA-1 AM (OGB-488) in organotypic slices of the rat brainstem
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indicator Case12 under the control of the GFAP promoter (Gourine
et al., 2010). Leptin evoked robust [Ca21]i responses in 40% of brain-
stem astrocytes that responded to ATP application (Figure 5a,b). The
threshold dose of leptin required to trigger [Ca21]i elevations in these
astrocytes was found to be 5 nM (Figure 5b).
To test whether changes in the neuronal activity induced by leptin
might be secondary to astroglial activation and mediated by the release
and actions of gliotransmitters, we next determined the effect of leptin
on [Ca21]i in astrocytes and neurons recorded in organotypic brainstem
slices (cut at the “pre-sympathetic level”) bulk-loaded with the Ca21 indi-
cator Oregon Green-488 BAPTA-1 AM (OGB-488). Astrocytes were
identified by labeling with sulforhodamine 101 (SR101) as described
previously (Turovsky et al., 2015). Cells labeled with SR101 displayed
robust [Ca21]i responses to ATP application and were insensitive to KCl
(Figure 5c), indicating that these cells are astrocytes. Leptin-induced
[Ca21]i responses in astrocytes were unaffected in the presence of P2Y
receptor antagonist MRS2179 or ATP-hydrolyzing enzyme apyrase (Fig-
ure 5c). In contrast, leptin-induced [Ca21]i responses in brainstem neu-
rons (identified by lack of SR101 labeling, and robust [Ca21]i responses
to KCl) were abolished by either MRS2179 or apyrase (Figure 5d).
Although the phenotype of the neurons recorded in these experiments
was not characterized, these results suggest that the CNS behavioral
and physiological effects of leptin may involve recruitment of astroglial
signaling pathways, release of gliotransmitter ATP and activation of the
neuronal purinergic receptors.
Together, these data suggest that astrocytes residing in brain
regions involved in the control of energy metabolism (hypothalamus
and the brainstem) are sensitive to key hormonal factors whose central
actions provide important information about the nutritional state and
energy demands of the organism. It remains to be determined whether
these sensitivities are exclusive features of astrocytes residing in brain
areas involved in metabolic control. It also remains to be determined
whether chronic exposure to the elevated levels of these hormones
may alter astroglial function and signaling mechanisms. This may have a
significant impact on the control of feeding behavior and cardiorespira-
tory homeostasis and ultimately contribute to the pathogenesis of met-
abolic and/or cardiovascular disease.
5 | SUMMARY
There is growing evidence to suggest that astrocytes actively monitor
CNS metabolic milieu and contribute to the development of adaptive
physiological respiratory, cardiovascular and behavioral responses
which maintain metabolic homeostasis. Anatomical and functional fea-
tures of astrocytes allow them to detect and respond to changes in the
brain parenchymal levels of metabolic substrates (O2 and glucose), met-
abolic by products (CO2), and hormonal metabolic factors involved in
the CNS mechanisms controlling food intake and energy balance. In
the brainstem, astrocytes modulate the activities of the neuronal cir-
cuits responsible for the generation of the respiratory and autonomic
rhythms and the development of the adaptive changes in breathing
and sympathetic nerve activity in conditions of increased metabolic
demand. The key signaling molecule which mediates communication
between astrocytes and the brainstem cardiorespiratory networks
appears to be ATP, although other gliotransmitters (e.g., lactate) may
also play a role. Furthermore, there is evidence that altered astroglial
function may contribute to the pathogenesis of disparate respiratory
and cardiovascular disorders such as Rett syndrome, heart failure and
systemic arterial hypertension.
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